Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Pharmaceuticals Secures USD $1.9 Million Sales Contract for SmoothX 2% (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Wayland Group Corp MRRCF

Healthcare Biotechnology Drug Manufacturers - Specialty & Generic Cannabis
Wayland Group Corp, formerly Maricann Group Inc produces and sells medical marijuana. It is currently engaged in cultivation, extraction, analytics and production facilities to elevate offerings and prepare for growth into the adult-use cannabis market in Canada.


GREY:MRRCF - Post by User

Wayland Group Corp
Bullboard Posts
User Avatar Image
(13)
•••
Comment by QcTraderon Nov 06, 2017 12:11pm
111 Views
Post# 26912150

RE:RE:RE:McKesson Deal

RE:RE:RE:McKesson Deal

Absolutely agree, also to note ACB acquisition of CanvasRX was at a price tag of roughly 15m shares plus bonuses.... at todays share price. yikes that was expensive :P 

 

truestar2 wrote: Sorry - meant, "How many Patients can Mari add with 3000 trained pharmacies."  The numbers are staggering, and again this is a groundbreaking deal that will lead to significant high margin growth.
Also sets a trend for the pharmaceutical space and it is likely Big Pharma will enter this space in the future similar to STZ and Canopy.  Mari immediately leads in the Pharma Space, and with NanoLeaf being developed for best THC and CBD delivery it puts us on the forefront for Large outside investment.

 

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities